|  Help  |  About  |  Contact Us

Publication : γδ T cells confer protection against murine cytomegalovirus (MCMV).

First Author  Khairallah C Year  2015
Journal  PLoS Pathog Volume  11
Issue  3 Pages  e1004702
PubMed ID  25747674 Mgi Jnum  J:245469
Mgi Id  MGI:5915464 Doi  10.1371/journal.ppat.1004702
Citation  Khairallah C, et al. (2015) gammadelta T cells confer protection against murine cytomegalovirus (MCMV). PLoS Pathog 11(3):e1004702
abstractText  Cytomegalovirus (CMV) is a leading infectious cause of morbidity in immune-compromised patients. gammadelta T cells have been involved in the response to CMV but their role in protection has not been firmly established and their dependency on other lymphocytes has not been addressed. Using C57BL/6 alphabeta and/or gammadelta T cell-deficient mice, we here show that gammadelta T cells are as competent as alphabeta T cells to protect mice from CMV-induced death. gammadelta T cell-mediated protection involved control of viral load and prevented organ damage. gammadelta T cell recovery by bone marrow transplant or adoptive transfer experiments rescued CD3epsilon-/- mice from CMV-induced death confirming the protective antiviral role of gammadelta T cells. As observed in humans, different gammadelta T cell subsets were induced upon CMV challenge, which differentiated into effector memory cells. This response was observed in the liver and lungs and implicated both CD27+ and CD27- gammadelta T cells. NK cells were the largely preponderant producers of IFNgamma and cytotoxic granules throughout the infection, suggesting that the protective role of gammadelta T cells did not principally rely on either of these two functions. Finally, gammadelta T cells were strikingly sufficient to fully protect Rag-/-gammac-/- mice from death, demonstrating that they can act in the absence of B and NK cells. Altogether our results uncover an autonomous protective antiviral function of gammadelta T cells, and open new perspectives for the characterization of a non classical mode of action which should foster the design of new gammadelta T cell based therapies, especially useful in alphabeta T cell compromised patients.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

11 Bio Entities

Trail: Publication

0 Expression